Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02391246 : Radionecrosis and FDG PET
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Age = 18 years old

- Able and willing to comply with the study procedures

- The patient must be followed at The Ottawa Hospital for a tissue-proven, grade III or
IV glioma.

- The patient must have been treated in the past with radiotherapy for glioma.

- A disease recurrence is suspected based on clinical symptoms and/or imaging results.

Exclusion Criteria:

- Missing information regarding tumor type and grade

- Brain biopsy in the ten days preceding DTPI FDG-PET

- Breastfeeding or pregnancy

- Claustrophobia or inability to lie still in a supine position

- Unwillingness or inability to provide informed consent
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02391246      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740